Literature DB >> 19346103

Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter.

Jens Treutlein1, Thomas W Mühleisen, Josef Frank, Manuel Mattheisen, Stefan Herms, Kerstin U Ludwig, Tsendsesmee Treutlein, Christine Schmael, Jana Strohmaier, Katja Veronika Bösshenz, René Breuer, Torsten Paul, Stephanie H Witt, Thomas G Schulze, Ralf G M Schlösser, Igor Nenadic, Heinrich Sauer, Tim Becker, Wolfgang Maier, Sven Cichon, Markus M Nöthen, Marcella Rietschel.   

Abstract

Recent linkage and association data have implicated the Glutamate Receptor Delta 1 (GRID1) locus in the etiology of schizophrenia. In this study, we sought to test whether variants in the promoter region are associated with this disorder. The distribution of CpG islands, which are known to be relevant for transcriptional regulation, was computationally determined at the GRID1 locus, and the putative transcriptional regulatory region at the 5'-terminus was systematically tagged using HapMap data. Genotype analyses were performed with 22 haplotype-tagging single nucleotide polymorphisms (htSNPs) in a German sample of 919 schizophrenia patients and 773 controls. The study also included two SNPs in intron 2 and one in intron 3 which have been found to be significantly associated with schizophrenia in previous studies. For the transcriptional regulatory region, association was obtained with rs3814614 (p=0.0193), rs10749535 (p=0.0245), and rs11201985 (p=0.0222). For all further analyses, the patient samples were divided into more homogeneous subgroups according to sex, age at onset, positive family history of schizophrenia and lifetime history of major depression. The p-value of the schizophrenia association finding for the three markers decreased by approximately one order of magnitude, despite the reduction in the total sample size. Marker rs3814614 (unadjusted p=0.0005), located approximately 2.0 kb from the transcriptional start point, also withstood a two-step correction for multiple testing (p=0.030). No support was obtained for previously reported associations with the intronic markers. Our results suggest that genetic variants in the GRID1 transcriptional regulatory region may play a role in the etiology of schizophrenia, and that future association studies of schizophrenia may require stratification to ensure more homogeneous patient subgroups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346103     DOI: 10.1016/j.schres.2009.03.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  35 in total

1.  Genome-wide association study of comorbid depressive syndrome and alcohol dependence.

Authors:  Alexis C Edwards; Fazil Aliev; Laura J Bierut; Kathleen K Bucholz; Howard Edenberg; Victor Hesselbrock; John Kramer; Samuel Kuperman; John I Nurnberger; Marc A Schuckit; Bernice Porjesz; Danielle M Dick
Journal:  Psychiatr Genet       Date:  2012-02       Impact factor: 2.458

Review 2.  Protein tyrosine phosphatases PTPδ, PTPσ, and LAR: presynaptic hubs for synapse organization.

Authors:  Hideto Takahashi; Ann Marie Craig
Journal:  Trends Neurosci       Date:  2013-07-05       Impact factor: 13.837

Review 3.  Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.

Authors:  Hongjie Yuan; Chian-Ming Low; Olivia A Moody; Andrew Jenkins; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

4.  The phenotype of recurrent 10q22q23 deletions and duplications.

Authors:  Bregje W M van Bon; Jorune Balciuniene; Gary Fruhman; Sandesh Chakravarthy Sreenath Nagamani; Diane L Broome; Elizabeth Cameron; Danielle Martinet; Eliane Roulet; Sebastien Jacquemont; Jacques S Beckmann; Mira Irons; Lorraine Potocki; Brendan Lee; Sau Wai Cheung; Ankita Patel; Melissa Bellini; Angelo Selicorni; Roberto Ciccone; Margherita Silengo; Annalisa Vetro; Nine V Knoers; Nicole de Leeuw; Rolph Pfundt; Barry Wolf; Petr Jira; Swaroop Aradhya; Pawel Stankiewicz; Han G Brunner; Orsetta Zuffardi; Scott B Selleck; James R Lupski; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

5.  Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways.

Authors:  Anthony J Griswold; Deqiong Ma; Holly N Cukier; Laura D Nations; Mike A Schmidt; Ren-Hua Chung; James M Jaworski; Daria Salyakina; Ioanna Konidari; Patrice L Whitehead; Harry H Wright; Ruth K Abramson; Scott M Williams; Ramkumar Menon; Eden R Martin; Jonathan L Haines; John R Gilbert; Michael L Cuccaro; Margaret A Pericak-Vance
Journal:  Hum Mol Genet       Date:  2012-04-27       Impact factor: 6.150

6.  Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia.

Authors:  C Christoph Schultz; Igor Nenadic; Kathrin Koch; Gerd Wagner; Martin Roebel; Claudia Schachtzabel; Thomas W Mühleisen; Markus M Nöthen; Sven Cichon; Thomas Deufel; Michael Kiehntopf; Marcella Rietschel; Jürgen R Reichenbach; Heinrich Sauer; Ralf G M Schlösser
Journal:  Neuropsychopharmacology       Date:  2011-04-20       Impact factor: 7.853

7.  A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.

Authors:  Jana Strohmaier; Josef Frank; Jens R Wendland; Johannes Schumacher; Rami Abou Jamra; Jens Treutlein; Vanessa Nieratschker; René Breuer; Manuel Mattheisen; Stefan Herms; Thomas W Mühleisen; Wolfgang Maier; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Thomas G Schulze
Journal:  Schizophr Res       Date:  2010-01-18       Impact factor: 4.939

8.  Enriched expression of GluD1 in higher brain regions and its involvement in parallel fiber-interneuron synapse formation in the cerebellum.

Authors:  Kohtarou Konno; Keiko Matsuda; Chihiro Nakamoto; Motokazu Uchigashima; Taisuke Miyazaki; Miwako Yamasaki; Kenji Sakimura; Michisuke Yuzaki; Masahiko Watanabe
Journal:  J Neurosci       Date:  2014-05-28       Impact factor: 6.167

9.  Gene discovery for high-density lipoprotein cholesterol level change over time in prospective family studies.

Authors:  Mary F Feitosa; Kathryn L Lunetta; Lihua Wang; Mary K Wojczynski; Candace M Kammerer; Thomas Perls; Nicole Schupf; Kaare Christensen; Joanne M Murabito; Michael A Province
Journal:  Atherosclerosis       Date:  2020-02-14       Impact factor: 5.162

Review 10.  A GluD Coming-Of-Age Story.

Authors:  Michisuke Yuzaki; A Radu Aricescu
Journal:  Trends Neurosci       Date:  2017-01-19       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.